Figure 1
Serum sIL-6R after tocilizumab infusion. Tocilizumab was administered to patients with RA (●; n = 5) or Castleman disease (■; n = 28) on days 0, 14, and 28 at a dose of 8 mg/kg. Points and error bars show geometric means plus or minus SDs.
Serum sIL-6R after tocilizumab infusion. Tocilizumab was administered to patients with RA (●; n = 5) or Castleman disease (■; n = 28) on days 0, 14, and 28 at a dose of 8 mg/kg. Points and error bars show geometric means plus or minus SDs.
